Episode Details

Back to Episodes
How a Pathologist for Prostate Cancer Reads a biopsy & Cribriform with Dr. Jonathan Epstein – 178

How a Pathologist for Prostate Cancer Reads a biopsy & Cribriform with Dr. Jonathan Epstein – 178

Episode 178 Published 1 month ago
Description

What if your prostate biopsy is missing the most important detail?

In this powerful episode, Dr. Geo sits down with Dr. Jonathan Epstein, one of the most influential urologic pathologists in the world, to break down what’s really happening behind your diagnosis.

From Gleason scores to hidden aggressive patterns, this conversation reveals why pathology is the foundation of every prostate cancer decision — and why getting it right is critical.

If you’ve had a biopsy, elevated PSA, or are considering treatment vs. surveillance… this episode is essential listening.

⏱️ Timestamps

00:00 – The Hidden Problem With Prostate Biopsies

Why your diagnosis may not tell the full story

02:00 – Meet Dr. Jonathan Epstein

A leader who helped define modern prostate cancer pathology

04:30 – What Pathologists Actually Look For

Understanding normal vs. abnormal prostate tissue

06:30 – Gleason Scores Explained Simply

What 3+3, 3+4, and 4+3 really mean

09:00 – Why Gleason 6 Is So Controversial

Should it even be called cancer?

11:00 – The Real Risk Isn’t Gleason 6

What doctors worry about more

13:00 – Active Surveillance: Who Is It For?

Why more men are safely avoiding treatment

14:30 – Pathology vs. Biology

How research connects what we see to outcomes

15:30 – The Most Important Details in Your Report

Cribriform patterns, intraductal cancer, and why they matter

17:00 – Understanding Gleason 7 (Grade Group 2 & 3)

Low-risk vs. high-risk within the same score

19:00 – When Cancer Becomes Dangerous

What defines aggressive disease

21:00 – Gleason 9: Is It Already Spread?

The truth about micro-metastasis

23:00 – Why MRI and PSMA Scans Aren’t Perfect

What imaging can miss

25:00 – Why Biopsies Still Matter

Even in the era of advanced imaging

26:00 – What Makes a “Good” Biopsy

Why technique matters more than you think

29:00 – MRI-Guided vs. Random Biopsies

Why both are still necessary

30:00 – How to Read Your Pathology Report

What actually matters vs. what doesn’t

34:00 – Biopsy vs. Prostatectomy Findings

Why results can change after surgery

36:00 – How Often Pathology Is Wrong

Why second opinions are critical

38:00 – The Problem Patients Don’t See

You don’t know who’s reading your biopsy

41:00 – The Future: AI in Pathology

Will machines replace doctors?

45:00 – What Patients Should Do Next

How to advocate for yourself

52:00 – Managing Anxiety Around PSA & Biopsies

A real conversation about fear

56:00 – What to Do When You Get Your Results

How to approach your doctor and next steps

01:03:00 – Final Advice: Take Control of Your Health

🧠 Key Takeaways

Pathology is the foundation of your diagnosis — everything else depends on it

Up to 20–30% of biopsy readings may change with expert review

Not all prostate cancer is dangerous — but some “low-risk” cases hide more aggressive disease

MRI and advanced imaging are powerful, but they can still miss cancer

A second opinion on your biopsy can completely change your treatment plan

📌 What to Ask Your Doctor

What is my Grade Group (not just Gleason score)?

Is there any cribriform or intraductal cancer present?

How many cores were positive and how much cancer was found?

Should I get a second pathology opinion?

Am I a candidate for active surveillance or treatment?

👤 About the Guest

Dr. Jonathan Epstein is a world-renowned urologic pathologist whose work has shaped how prostate cancer is diagnosed globally. Formerly at Johns Hopkins, he has trained over 90 specialists and continues to influence the field through clinical work and research.

Listen Now